ABBV-969 Payload is a drug-linker conjugate featuring a topoisomerase I inhibitor for constructing antibody-drug conjugates (ADCs). It is designed for coupling to anti-c-Met antibodies, enabling targeted delivery for anticancer research in both in vitro and in vivo experimental models.